These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35394594)

  • 1. Duodenal Follicular Lymphoma: Track or Treat?
    Varanese M; Lauro A; Lattina I; Tripodi D; Daralioti T; Khouzam S; Marino IR; Stigliano V; D'Andrea V; Frattaroli S; Sorrenti S
    Dig Dis Sci; 2022 May; 67(5):1733-1738. PubMed ID: 35394594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine-Rituximab.
    Rajabto W; Harahap AS; Putra HN
    Acta Med Indones; 2024 Apr; 56(2):249-252. PubMed ID: 39010773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnifying Endoscopic Observation of Duodenal Involvement of Follicular Lymphoma before and after Chemotherapy.
    Iwamuro M; Okada H; Takata K; Fujii N; Kawano S; Kawahara Y; Yoshino T; Yamamoto K
    Intern Med; 2015; 54(14):1741-5. PubMed ID: 26179528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Follicular (nodular) non Hodgkin's lymphoma of tonsil--case report].
    Osuch-Wójcikiewicz E; Rzepakowska A; Bruzgielewicz A; Wieczorek J
    Otolaryngol Pol; 2007; 61(2):203-6. PubMed ID: 17668812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL).
    Boccomini C; Ladetto M; Rigacci L; Puccini B; Rattotti S; Volpetti S; Ferrero S; Chiarenza A; Freilone R; Novo M; Corradini P; Nassi L; Rusconi C; Stelitano C; Bolis S; Marina Liberati A; Tucci A; Baldini L; Balzarotti M; Evangelista A; Ciccone G; Vitolo U
    Br J Haematol; 2021 Apr; 193(2):280-289. PubMed ID: 33476434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian Follicular Lymphoma Diagnosed Due to Hydronephrosis.
    Noguchi S; Kimura Y; Shibano S; Ariake C; Iwasawa T; Oyama N; Sato H; Enomoto K; Takahashi N
    Intern Med; 2023 Jan; 62(2):293-298. PubMed ID: 35732447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
    Trotman J; Cheah CY; Marlton P; Opat S
    Intern Med J; 2019 Apr; 49(4):422-433. PubMed ID: 30230156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary duodenal follicular lymphoma: 6-years complete remission after combined radio-immunotherapy.
    Franco P; Filippi AR; Ciammella P; Botticella A; Namysl-Kaletka A; De Crescenzo A; Tarella C; Ricardi U
    Acta Gastroenterol Belg; 2011 Jun; 74(2):337-42. PubMed ID: 21861321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study.
    Mondello P; Steiner N; Willenbacher W; Cerchione C; Nappi D; Mauro E; Ferrero S; Cuzzocrea S; Mian M
    Oncologist; 2018 Apr; 23(4):454-460. PubMed ID: 29317554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathological features of duodenal-type follicular lymphoma].
    Zhang F; Luo DL; Chen Y; He J; Yan JH; Luo LQ; Luo XL; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Jan; 48(1):22-25. PubMed ID: 30641641
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical analysis of eight patients with primary follicular lymphoma in the duodenum].
    Tsujioka T; Wada H; Yata K; Kondo T; Suemori S; Tokunaga H; Ohmori K; Kubo Y; Nakanishi H; Mikami M; Haruma K; Sadahira Y; Sugihara T
    Rinsho Ketsueki; 2007 Feb; 48(2):134-9. PubMed ID: 17370641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
    Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
    Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of "watch and wait" in intestinal follicular lymphoma in rituximab era.
    Tari A; Asaoku H; Takata K; Fujimori S; Tanaka S; Fujihara M; Koga T; Yoshino T
    Scand J Gastroenterol; 2016 Mar; 51(3):321-8. PubMed ID: 26382560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary follicular lymphoma of the duodenum: a case report and review of literatures.
    Charoenlap C; Akarapatima K; Suwanno K; Rattanasupar A; Chang A
    Gastroenterol Hepatol Bed Bench; 2021; 14(2):185-189. PubMed ID: 33968348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in the therapy of stage III and IV follicular lymphoma: Results of the REFLECT 1 study of the Serbian Lymphoma Group.
    Popovic S; Jovanovic D; Mihaljevic B; Andjelkovic N; Marjanovic G; Marisavljevic D; Vlaisavljevic N; Popovic L; Salma S; Agic D; Milosevic R; Smiljanic M; Sretenović S; Djurdjević P; Markovic O; Hajder J; Govedarovic N
    J BUON; 2017; 22(2):487-494. PubMed ID: 28534374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.
    Keating GM
    Drugs; 2010 Jul; 70(11):1445-76. PubMed ID: 20614951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.
    Nastoupil LJ; Sinha R; Byrtek M; Ziemiecki R; Zhou X; Taylor M; Friedberg JW; Link BK; Cerhan JR; Dawson K; Flowers CR
    Br J Haematol; 2016 Mar; 172(5):724-34. PubMed ID: 26729445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
    Czuczman MS; Weaver R; Alkuzweny B; Berlfein J; Grillo-López AJ
    J Clin Oncol; 2004 Dec; 22(23):4711-6. PubMed ID: 15483015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.